Cargando…
The effects of tetrahydrobiopterin (BH(4)) treatment on brain function in individuals with phenylketonuria()
Phenylketonuria (PKU) is a rare genetic condition characterized by an absence or mutation of the PAH enzyme, which is necessary for the metabolism of the amino acid phenylalanine into tyrosine. Recently, sapropterin dihydrochloride, a synthetic form of tetrahydrobiopterin (BH(4)), has been introduce...
Autores principales: | Christ, Shawn E., Moffitt, Amanda J., Peck, Dawn, White, Desirée A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871382/ https://www.ncbi.nlm.nih.gov/pubmed/24371792 http://dx.doi.org/10.1016/j.nicl.2013.08.012 |
Ejemplares similares
-
The effects of early-treated phenylketonuria on volumetric measures of the cerebellum
por: Aldridge, Kristina, et al.
Publicado: (2020) -
One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4)
por: Brantley, Kristen D, et al.
Publicado: (2018) -
The challenge of long-term tetrahydrobiopterin (BH(4)) therapy in phenylketonuria: Effects on metabolic control, nutritional habits and nutrient supply
por: Thiele, Alena G., et al.
Publicado: (2015) -
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH(4)) deficiencies
por: Opladen, Thomas, et al.
Publicado: (2020) -
Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan
por: Carducci, Carla, et al.
Publicado: (2020)